Copper in circulatory disease;Rola miedzi w chorobach układu krazenia

Polski Przeglad Kardiologiczny

Volumn 5, Issue 3, 2003, Pages 325-329

  Goch, Aleksander ^a  

^a Nadcisnienia Tetniczego UM ^*  (Poland)

Author keywords

Arterial hypertension; Cardiomyopathy; Copper; Ischaemic heart disease

Indexed keywords

CERULOPLASMIN; COPPER;

BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATALYST; DEATH; DISEASE ACTIVITY; HEART DILATATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; OXIDATION REDUCTION REACTION; PATHOGENESIS; PROSPECTIVE STUDY; REFERENCE VALUE; REVIEW;

EID: 0141425872     PISSN: 15075540     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Jendryczko A., Droizdz M., Magner K.: Fizjologia stanów niedoboru miedzi. Pol. Tyg. Lek., 1986, 41, 227-229.
2. Miniuk K., Moniuszko-Jakoniuk M., Kulikowska E.: Biodostepność oraz stany chorobowe przy niedoborze miedzi. Pol. Tyg. Lek., 1991, 46, 476-478.
3. Linder M.C., Hazegh-Azam M.: Copper biochemistry and molecular biology. Am. J. Clin. Nutr., 1996, 63, 797s-811s.
4. Milne D.B.: Copper intake and assessment of copper status. Am. J. Clin. Nutr., 1998, 67, supl., 1041s-1045s.
5. Turnlund J.R., Keen C.L., Smith R.G.: Copper status and urinary and salivary copper in yonng men at three levels of dietary copper. Am. J. Clin. Nutr., 1990, 51, 658-664.
6. Turnlund J.R.: Copper nutriture, bioavailability, and the influence of dietary factors. J. Am. Diet. Assoc., 1988, 88, 303-308.
7. Lönnerdal B.: Bioavailability of copper. Am. J. Clin. Nutr., 1996, 63, 821s-829s.
8. Turnlund J.R., Keyes W.R., Peiffer G.L. i wsp.: Copper absorption, excretion, and retention by young men consuming low dietary copper determined by using the stable isotope 65 Cu. Am. J. Clin. Nutr., 1998, 67, 1219-1225.
9. Turnlund J.R.: Human whole - body copper metabolism. Am. J. Clin. Nutr., 1998, 67, supl., 960S-964S.
10. Halliwell B.: Oxidative stress, nutrition and health. Experimental strategies for optimalization of nutritional antioxidant intake in humans. Free Rad. Res., 1996, 25, 57-74.
11. Ziouzenkova O., Sevanian A., Abuja P.M. i wsp.: Copper can promote oxidation of LDL by markedly different mechanisms. Free Radic. Biol. Med., 1998, 24, 607-623.
12. Koningsberger J.C., van Asbeck B.S., van Faassen E. i wsp.: Copper, zinc - superoxidase dismutase and hydrogen peroxide: a hydroxyl radical generating system. Clin. Chim. Acta, 1994, 230,51-61.
13. Fox P.L., Mukhopadhyay C., Ehrenwald E.: Structure, oxidant activity and cardiovascular mechanisms of human ceruloplasmin. Life Sci., 1995, 56, 1749-1758.
14. Salonen J.T., Salonen R., Korpela H. i wsp.: Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern Filand. Am. J. Epidemiol., 1991, 134, 268-276.
15. Kok F.J., Van Duijn C.M., Hofman A. i wsp.: Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am. J. Epidemiol., 1998, 128, 352-359.
16. Ford E.S.: Serum Copper Concentration and Coronary Heart Disease among US Adults. Am. J. Epidemiol., 1992, 151, 1182-1188.
17. Kromhout D., Wibowo A.A., Herber R.F. i wsp.: Trace metals and coronary heart disease risk indicators in 152 elderly men (the Zutphen Study). Am. J. Epidemiol., 1985,122,378-385.
18. Tiber A.M., Sakhaii M., Joffe C.D. i wsp.: Relative value of plasma copper, zinc, lipids and lipoproteins as markers for coronary artery disease. Atherosclerosis, 1986, 62, 105-110.
19. Manthey J., Stoeppler M., Morgenstern W. i wsp.: Magnesium and trace metals. risk factors for coronary heart disease? Association between blood levels and angiographic findings. Circulation, 1981, 64, 722-729.
20. Oster O., Dahm M., Oelert H. i wsp.: Concentrations of some trace elements (Se, Zn, Cu, Fe, Mg, K) in blood and heart tissue of patients with coronary heart disease. Clin. Chem., 1989, 35, 851-856.
21. Chipperfield B., Chipperfield J.R.: Differences in metal content of the heart muscle in death from ischemic heart disease. Am. Heart J., 1978, 95, 732-737.
22. Vlad M., Caseanu E., Uza G. i wsp.: Concentration of copper, zinc, chromium, iron and nickel in the abdominal aorta of patients deceased with coronary heart disease. J. Trace Elem. Electrolytes Health Dis., 1994, 8, 111-114.
23. Dubick M.A., Hunter G.C., Carey S.M. i wsp.: Aortic ascorbic acid trace elements and superoxide dismutase activity in human aneurysmal and occlusive disease. Proc. Soc. Exp. Biol. Med., 1987, 184, 138-143.
24. Jain V.K., Mohan G.: Serum zinc and copper in myocardial infarction with particular reference to prognosis. Biol. Trace Elem. Res., 1991, 31, 317-322.
25. Reunanen A., Knekt P., Aaran R.K.: Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am. J. Epidemiol., 1992, 136, 1082-1090.
26. Harman D.: Role of serum copper in coronary atherosclerosis. (abstract). Circulation, 1963, 28, 658.
27. Halawa B.: Zakazenia a choroba niedokrwienna serca. Pol. Merk. Lek., 2002, 13, 58-61.
28. Tataru M.C., Heinrich J., Junker R. i wsp.: C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur. Heart J., 2000, 21, 1000-1008.
29. Cousins R.J.: Absorption, transport, and hepatic metabolism of copper and zinc.: special reference to metallothionein and ceruloplasmin. Phys. Rev., 1985, 65, 238-309.
30. Klipstein-Grobousch K., Grobbee D.E., Koster J. F. i wsp.. Serum caeruloplasmin as coronary risk factor in the elderly. The Rotterdam Study. Br. J. Nutr., 1999, 81, 139-144.
31. Oster O.: Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy. Clin. Chim. Acta, 1993, 214, 209-218.
32. Kopp S.J., Klevay L.M., Feliksik J.M.: Physiological and metabolic characterization of a cardiomyopaty induced by chronic copper deficiency. Am. J. Physiol., 1983, 245 (Heart Circ. Physiol. 14), H855-H866.
33. Medeiros D.M., Davidson J., Jenkins J.E.: A unified perspective in copper deficiency and cardiomyopathy (43599). PSEBM, 1993, 203, 262-273.
34. Klevay L.M., Inman L., Johnson L.K. i wsp.: Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism, 1984, 1112-1118.
35. Klevay L. M., Viestenz K. E.: Abnormal electrocardiograms in rats deficient in copper. Am. J. Physiol., 1981, 240 (Heart Circ. Physiol. 9), H185-H189.
36. Lukaski H.C., Klevay L.M., Milne D.B.: Effects of dietary copper on human autonomic cardiovascular function. Eur. J. Appl. Physiol., 1988, 58,74-80.
37. Prohaska J.R., Heller L.J.: Mechanical properties of the copper deficient rat heart. J. Nutr., 1982, 112, 2142-2150.
38. Klevay L.M., Moore R.J., Leslie M.: Effect of copper deficiency on blood pressure and plasma and lung angiotensin - converting enzyme activity in rats. Nutr. Res., 1988, 8,489-497.
39. Olatunbosum D.A., Blodeku I.O., Cole I.O. i wsp.: Relationship of serum copper and zinc to human hypertension in Nigerians. Bull. World Health Organ., 1976, 53, 134-135.
40. Akanle O.A., Akitanmide A., Durosinmi M.A. i wsp.: Elemental analysis of blood of Nigerian hypertensive subjects. Biol. Trace Elem. Res., 1999, 71-72, 611-616.
41. Vivoli G., Borella P., Bergomi M. i wsp.: Zinc and copper levels in serum, urine, and hair of humans in relation to blood pressure. Sci. Total Environ., 1987, 66, 55-64.
42. Staessen J., Sartor F., Roels H. i wsp.: The association between blood pressure, calcium and other divalent cations: a population study. J. Hum. Hypertens., 1991, 5, 485-494.
43. Vivoli G., Bergomi M., Rovesti S. i wsp.: Zinc, copper, and zinc or copper - dependent enzymes in human hypertension. Biol. Trace Elem. Res., 1995, 49, 97-106.
44. Rubio-Luengo M.A., Maldonado-Martin A., Gil Extremera B. i wsp.: Variations in magnesium and zinc in hypertensive patients receving different treatments. Am. J. Hypertens., 1995, 8, 689-695.
45. Bergomi M., Rovesti S., Vincenti M. i wsp.: Zinc and copper status and blood pressure. J. Trace Elem. Med. Biol., 1997, 11, 166-169.
46. Chen M.D., Sheu W.H.: Plasma status of selected minerals in hypertensive men with and without insulin resistance. J. Trace Elem. Med. Biol., 2001, 14, 228-231.
47. Berthelot A., Luthringer C., Exinger A.: Trace elements during the development of hypertension in the spontaneously hypertensive rats. Clin. Sci. (Colch.)., 1987, 72, 515-518.
48. Loyke H.F.: Copper and zinc in experimental hypertension. Biol. Trace Elem. Res., 1991, 29, 45-49.
49. Clegg M.S., Ferrell F., Keen C.L.: Hypertension - induced alterations in copper and zinc metabolism in dahl rats. Hypertension, 1987, 9, 624-628.
50. Garrow T.A., Clegg M.S., Metzler G. i wsp.: Influence of hypertension and dietary copper on indexes of copper status in rats. Hypertension, 1991, 17, 793-797.
51. Sentürk Ü.K., Kaputlu I., Gündüz F. i wsp.: Tissue and blood levels of zinc, copper and magnesium in nitric oxide synthase blockade - induced - hypertensivn. Biol. Trace Elem. Res., 2000, 77, 97-106.
52. Stevens M. D., Di Silvestro R.A., Harris E.D.: Specific receptors for ceruloplasmin in membrane fragments from aortic and heart tissue. Biochemistry, 1984, 23, 261-266.
53. Frieden E.: Perspectives on copper biochemistry. Clin. Physiol. Biochem., 1986, 4, 11-19.
54. Hunsacker H.A., Morita M., Allen K.G.D.: Marginal copper deficienty in rats. Aortal morphology of elastin and cholesterol values in firt - generation adult males. Atherosclerosis, 1984, 51, 1-19.
55. Saari J.T.: Dietary copper deficiency and endotheliun dependent relaxation of rat aorta. Proc. Soc. Exp. Biol. Med., 1992, 200, 19-24.
56. Kinsman G.D., Howard A.N., Stone D.L. i wsp.: Studies in copper status and atherosclerosis. Biochem. Soc. Trans., 1990, 18, 1186-1188.
57. Klevay L.M., Bistrian B.R., Fleming C.R. i wsp.: Hair analysis in clinical and experimental medicine. Am. J. Clin. Nutr., 1987, 46, 233-236.
58. Milne D.B.: Assessment of copper nutritional status. Clin. Chem., 1994, 40, 1479-1484.
59. Uauy R., Castillo-Duran C., Fisberg M. i wsp.: Red cell superoxide dismutase activity as an of human copper nutrition. J. Nutr., 1985, 115, 1650-1655.
60. Klevay L. M.: Coronary heart disease: the zinc/copper hypothesis. Am. J. Clin. Nutr., 1975, 28, 764-774.
61. Manttari M., Manninen V., Huttunen J.K. i wsp.: Serrum fervitin and ceruloplasmin as coronary risk factors. Eur. Heart J., 1994, 15, 1599-1603.